GMILogo_Vertical-Gradient.png
Point of Care Ultrasound Market to hit USD 5.5 Billion by 2030, says Global Market Insights Inc.
November 22, 2022 05:26 ET | Global Market Insights Inc.
Selbyville, Delaware, Nov. 22, 2022 (GLOBE NEWSWIRE) -- The point of care ultrasound market value is set to reach USD 5.5 billion by 2030, according to a new research report by Global Market...
Mainz BioMed LOGO PANTONE@4x-100.jpg
Mainz Biomed Announces U.S. Extension of ColoFuture Study to Evaluate Integration of Novel mRNA Biomarkers into ColoAlert
November 15, 2022 08:00 ET | Mainz BioMed NV
eAArly DETECT expected to complete enrollment in Q1 2023 with results in 1H 2023Enhances ColoFuture’s demographic profile and expedites data read-out timelinePotential to identify advanced adenomas, a...
cmi_logo.png
[Latest] Global Respiratory Diagnostics Market Size/Share Worth USD 13.80 Billion by 2030 at an 8.5% CAGR: Custom Market Insights (Testing, Devices, Infection, Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth)
November 08, 2022 11:58 ET | Custom Market Insights
Sandy, Utah, USA, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Respiratory Diagnostic Market Size, Trends and Insights By Product and Services...
Mainz BioMed LOGO PANTONE@4x-100.jpg
Mainz Biomed Provides Third Quarter 2022 Update
November 02, 2022 08:00 ET | Mainz BioMed NV
BERKELEY, Calif. and MAINZ, Germany, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the...
Daniel Cloutier
Daniel Cloutier, a Veteran Sales Executive, Joins Brain Scientific as Chief Revenue Officer
November 01, 2022 10:23 ET | Brain Scientific Inc.
LAKEWOOD RANCH, Fla., Nov. 01, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Brain Scientific (OTCQB:BRSF), a Florida-based medical device technology company, announces today that Daniel Cloutier is...
TIP_link_300x300.jpg
$55+ Billion Stroke Management Market Size to Rise at a Stellar CAGR of 7.5% During (2022-2028) - COVID-19 Impact and Global Analysis by The Insight Partners
October 18, 2022 08:40 ET | The Insight Partners
New York, Oct. 18, 2022 (GLOBE NEWSWIRE) -- According to The Insight Partners latest market study on "Stroke Management Market Size, Share, Trends, Growth Strategy and Forecast to 2028 – COVID-19...
Diagnostic Imaging Services Market Size Worth USD 865 Billion by 2030 at 5.30% CAGR – Report by Market Research Future (MRFR)
September 26, 2022 09:30 ET | Market Research Future
New York, USA, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Diagnostic Imaging Services Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Diagnostic Imaging...
attralus-logo.png
Attralus Announces New Clinical Data in ATTR CM and AL With AT-01 (Iodine (I-124) Evuzamitide), a Novel Amyloid-Specific Imaging Agent
September 12, 2022 07:00 ET | Attralus, Inc
AT-01 shows increased LV uptake and LV amyloid activity in all cardiac ATTR and AL subjects, but in none of the controls (100% accuracy)AT-01 demonstrates significantly higher left ventricular uptake...
attralus-logo.png
Attralus Announces Presentation of Clinical Data for AT-01 (Iodine (I-124) Evuzamitide), a Novel Amyloid-Specific Imaging Agent, at the 18th International Symposium on Amyloidosis
September 08, 2022 07:00 ET | Attralus, Inc
AT-01 is a first-in-class pan-amyloid imaging agent capable of detecting diverse types of systemic amyloidosis in multiple organsSensitivity in those with previously diagnosed cardiac disease was 100%...
Straits Research Pvt Ltd
Endoscopic Retrograde Cholangiopancreatography Market Size is projected to reach USD 2.22 Billion by 2030, growing at a CAGR of 7%: Straits Research
August 31, 2022 11:40 ET | Straits Research
New York, United States, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Endoscopic retrograde cholangiopancreatography, or ERCP, is a diagnostic and therapeutic procedure that uses upper gastrointestinal (GI)...